NASDAQ: UNCY Unicycive’s Doug Jermasek, EVP-Corporate Development Talks Medication Compliance

Unicycive Therapeutics, Inc. is a biotechnology company dedicated to developing treatments for certain medical conditions. The Company is focused on identifying medical conditions within and outside of kidney disease.